Sayegh MH - Search Results

1

Magee CC, Sayegh MH. Magee CC, et al. Among authors: sayegh mh. Curr Opin Immunol. 1997 Oct;9(5):669-75. doi: 10.1016/s0952-7915(97)80047-7. Curr Opin Immunol. 1997. PMID: 9368776 Review.

2

In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide.

Magee CC, Azuma H, Knoflach A, Denton MD, Chandraker A, Iyer S, Buelow R, Sayegh M. Magee CC, et al. J Am Soc Nephrol. 1999 Sep;10(9):1997-2005. doi: 10.1681/ASN.V1091997. J Am Soc Nephrol. 1999. PMID: 10477153

3

Peptide mediated immunosuppression: new developments.

Magee CC, Sayegh MH. Magee CC, et al. Among authors: sayegh mh. Transplant Proc. 1998 Aug;30(5):2131-5. doi: 10.1016/s0041-1345(98)00563-6. Transplant Proc. 1998. PMID: 9723416 Review. No abstract available.

4

Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides.

Vella JP, Magee C, Vos L, Womer K, Rennke H, Carpenter CB, Hancock W, Sayegh MH. Vella JP, et al. Among authors: sayegh mh. Transplantation. 1999 Jun 27;67(12):1523-32. doi: 10.1097/00007890-199906270-00005. Transplantation. 1999. PMID: 10401758

5

Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.

Stadlbauer TH, Schaub M, Magee CC, Kupiec-Weglinski JW, Sayegh MH. Stadlbauer TH, et al. Among authors: sayegh mh. J Heart Lung Transplant. 2000 Jun;19(6):566-75. doi: 10.1016/s1053-2498(00)00098-x. J Heart Lung Transplant. 2000. PMID: 10867337

6

Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.

Sayegh MH, Zheng XG, Magee C, Hancock WW, Turka LA. Sayegh MH, et al. Transplantation. 1997 Dec 27;64(12):1646-50. doi: 10.1097/00007890-199712270-00003. Transplantation. 1997. PMID: 9422396

7

Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.

Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF. Chowdhury NC, et al. Among authors: sayegh mh. Transplantation. 1998 Oct 27;66(8):1059-66. doi: 10.1097/00007890-199810270-00016. Transplantation. 1998. PMID: 9808492

8

Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.

Murphy B, Magee CC, Alexander SI, Waaga AM, Snoeck HW, Vella JP, Carpenter CB, Sayegh MH. Murphy B, et al. Among authors: sayegh mh. J Clin Invest. 1999 Mar;103(6):859-67. doi: 10.1172/JCI5734. J Clin Invest. 1999. PMID: 10079107 Free PMC article.

9

Immunosuppressive strategies in transplantation.

Denton MD, Magee CC, Sayegh MH. Denton MD, et al. Among authors: sayegh mh. Lancet. 1999 Mar 27;353(9158):1083-91. doi: 10.1016/S0140-6736(98)07493-5. Lancet. 1999. PMID: 10199367 Review. No abstract available.

10

Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection.

Knoflach A, Magee C, Denton MD, Kim KS, Buelow R, Hancock WW, Sayegh MH. Knoflach A, et al. Among authors: sayegh mh. Transplantation. 1999 Mar 27;67(6):909-14. doi: 10.1097/00007890-199903270-00020. Transplantation. 1999. PMID: 10199742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters